Crit Care Med. 2016 Jan AUTHORS: Welch TP et al OBJECTIVE: To evaluate the clinical effectiveness of bolus-dose fentanyl and midazolam to treat episodic intracranial hypertension in children with severe traumatic brain injury. DESIGN: Retrospective cohort. SETTING: PICU in a university-affiliated children’s hospital level I trauma center. PATIENTS: Thirty-one children aged 0-18 years with severe traumatic […]
Read MoreSurg Today. 2015 Dec 23 AUTHORS: Shibasaki S et al PURPOSE: To clarify the efficacy of postoperative pain management following laparoscopic gastrectomy (LG), we retrospectively compared pain assessments in patients who received fentanyl plus celecoxib with those who received epidural anesthesia. METHODS: From 2011 to 2012, 55 consecutive LG patients at our institution received 48 h of […]
Read MoreSerum levels of the pro-inflammatory cytokine interleukin-6 (IL-6) vary in individuals with lumbar intervertebral disc disease and biochemical profiling of circulating cytokines may assist in refining personalised diagnoses of disc diseases, according to a study published in the journal Arthritis Research and Therapy. Low back pain is caused by multiple triggers that present in similar ways. […]
Read MoreResearchers have found a link between dry eye and chronic pain syndromes — a finding that suggests that a new paradigm is needed for diagnosis and treatment to improve patient outcomes. “Our study indicates that some patients with dry eye have corneal somatosensory pathway dysfunction and would be better described as having neuropathic ocular pain,” […]
Read MoreMethylnaltrexone, a peripherally acting μ-opioid receptor (MOR) antagonist, may play a role in slowing tumor progression, new research has found. According to the study, methylnaltrexone influenced cancer progression and prolonged survival in patients with advanced cancer, suggesting that the MOR antagonist may be an important therapeutic target. “Our data suggest that methylnaltrexone used in advanced […]
Read More